
    
      This is a randomized controlled trial with three intervention arms: en_l√≠nea, standard group
      therapy and control group. To perform this study, 305 adults (18-65 years) with overweight
      type II (27-29.9 kg/m2) or obesity type I (30-34.9 kg/m2) will be invited to participate.
      Interventions will last 17 weeks with follow-ups 1, 3, 6 and 12 months after the
      post-treatment appointment. The primary outcome will be post-treatment weight loss and the
      maintenance during the follow-ups. Secondary outcomes will be adherence rates, drop outs and
      quality of life. Participants will be assessed before randomization and they will be sign an
      inform consent.
    
  